Catalyst Wire Dossier Catalyst Wire Dossier

Oxybutynin chloride OROS

oxybutynin chloride · Janssen Korea, Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oxybutynin chloride OROS, covering 2013-09-16 to 2013-09-16. Get the full timeline:

Most recent: Clinical Trial Update: An Efficacy and Safety Study of Oxybutynin Chloride Oral Osmotic Therapeutic System (OROS) in Korean Overactive Bladder Participants [Phase 4]

See pricing